On June 16, 2015, Jeffrey S. Weber, M.D., Ph.D., discussed the cancer immunity cycle and the importance of antigen release and presentation to maximize the potential of immunotherapies.

Jeffrey S. Weber, M.D., Ph.D., is a senior member, director of the Donald A. Adam Comprehensive Melanoma Research Center of Excellence (MRCoE), and professor in the department of oncologic sciences at Moffitt Cancer Center. As a tumor immunologist and immunotherapist, he focuses on translational clinical trials, including the development of novel trials in melanoma. His laboratory interests are in the monitoring and characterization of T cell responses in patients with cancer, and the establishment of in vitro models to facilitate the understanding of how immune modulation via abrogating and activating antibodies amplifies adaptive immunity in patients. Dr. Weber earned his Ph.D. in molecular cell biology from The Rockefeller University in 1979 and his M.D. from New York University Medical Center in 1980. Dr. Weber has published more than 100 articles in the top peer-reviewed journals in his field.

This webinar, which is part of the Cancer Research Institute’s Breakthroughs in Cancer Immunotherapy Webinar Series, was generously supported by Amgen. It is offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.
Video Rating: / 5